Thanks for that pickup Vintage.
I just went back and checked because I had thought that efficacy of diagnosing stroke location and type was a part of the stage 2 endpoints although I got that wrong.... my mistake.
Given that clarification I agree with you that a commercial distribution partnership will likely follow the validation phase.
Thanks for that pickup Vintage.I just went back and checked...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.91 |
Change
0.050(2.69%) |
Mkt cap ! $163.1M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.82 | $236.2K | 128.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.91 | 596 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.86 |
Change
0.050 ( 0.79 %) |
||||
| Open | High | Low | Volume | ||
| $1.86 | $1.86 | $1.82 | 7659 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| EMV (ASX) Chart |